Indole Compound Derivatives for Atopic Dermatitis Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for atopic dermatitis (AD) face challenges such as limited therapeutic efficacy, safety concerns, and drug resistance, necessitating the development of safer and more effective small molecule drugs from natural sources.
Innovation Solution
Development of structurally optimized indole compounds, including derivatives like indole-3-carboxaldehyde and indole-3-methanol, which are tested on a mouse model to alleviate AD-like symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional drugs (corticosteroids, calcineurin inhibitors, antibiotics) are used to treat atopic dermatitis, then therapeutic effects are achieved, but safety concerns and adverse effects occur
Solution Approach 1:
The patent changes the chemical structure parameters by introducing indole core with specific substituents (formula I structure) to create compounds with different pharmacological properties that maintain therapeutic efficacy while reducing adverse effects associated with traditional drugs
Solution Approach 2:
The patent develops small molecule indole compounds that can be administered orally with good bioavailability, replacing traditional long-term use of corticosteroids and antibiotics that cause accumulation of adverse effects
2Duration of action of stationary object
If traditional drugs are used long-term, then AD symptoms are controlled, but drug resistance and microbial recolonization occur
Solution Approach 1:
The patent modifies the chemical structure parameters of the compounds (formula I with various R1-R8 groups) to create molecules with novel mechanisms of action that do not promote microbial resistance, allowing for long-term treatment without developing drug resistance
Solution Approach 2:
The patent extracts the active therapeutic components from natural sources (indole structure) and optimizes them into small molecule compounds that can be used long-term without the resistance problems associated with conventional antibiotics and immunosuppressants
3Object-affected harmful factors
If moisturizers are used to improve dry skin condition, then skin hydration is enhanced, but therapeutic effect is limited
Solution Approach 1:
The patent replaces the mechanical/physical mechanism of moisturizers (surface occlusion to prevent moisture loss) with a pharmacological mechanism where indole compounds actively modulate skin barrier function and inflammation through biological receptors
Solution Approach 2:
The patent changes the functional parameters from passive moisture retention to active skin barrier repair and anti-inflammatory effects through the indole compound mechanism
4Object-affected harmful factors
If antibiotics are used to eliminate pathogenic microbes, then infections are treated, but long-term use induces drug-resistant strains
Solution Approach 1:
The patent develops small molecule indole compounds with novel mechanisms of action that do not exert selective pressure for resistance development, allowing for sustained use without inducing drug-resistant microbial strains
Solution Approach 2:
The patent changes the mechanism of action from traditional antibiotic cell wall synthesis inhibition or protein synthesis disruption to indole compound-mediated modulation of skin barrier function and anti-inflammatory effects, eliminating the driver of microbial resistance
Data Source
AI summary
A class of indole compounds is provided, their preparation methods and use thereof, which belong to the technical field of pharmaceutical chemistry. The compounds represented by formula I have a well therapeutic effect on atopic dermatitis.